Stock Report MoonLake Immunotherapeutics - Ordinary Shares - Class A with In-Depth Stock Analysis

MoonLake Immunotherapeutics - Ordinary Shares - Class A XNAS: MLTX

37.60 -1.66 (-4.23%)

33.88% Fall from 52W High

568.0K XNAS Volume

XNAS 07 May, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for MoonLake Immunotherapeutics - Ordinary Shares - Class A took place on 07 May 2025, for the purpose of MoonLake Immunotherapeutics First Quarter Earnings Results for 2025 See details

33.88% Fall from 52W High

Detailed Stock Analysis for MoonLake Immunotherapeutics - Ordinary Shares - Class A with Real-time Stock Report